These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [The effect of membrane-active compounds on the radiation-modifying effect of glucose in x-irradiated ascitic tumor cells]. Obrokov AF; Letov VN; Veksler AM Radiobiologiia; 1991; 31(6):856-60. PubMed ID: 1767017 [TBL] [Abstract][Full Text] [Related]
47. Cycloheximide treatment modifies the pattern of "metastasis" following intravenous injection of Ehrlich ascites tumour cells. Parry EW Gan; 1981 Jun; 72(3):464-7. PubMed ID: 7319203 [TBL] [Abstract][Full Text] [Related]
48. [Inhibition of pinocytosis and of acid phosphatase activity caused by lack of serum in the culture medium of Ehrlich ascites tumor cells (author's transl)]. Pfab R; Schachtschabel DO; Paul N; Hess F Strahlentherapie; 1979 Jan; 155(1):51-7. PubMed ID: 760277 [No Abstract] [Full Text] [Related]
49. Effect of the stress on the mitotic activity of the Ehrlich ascites tumour cells. Markov GG; Raitcheva E C R Acad Bulg Sci; 1967; 20(6):587-90. PubMed ID: 5601636 [No Abstract] [Full Text] [Related]
51. Transformed liver cells have modified transplasma membrane redox activity which is sensitive to adriamycin. Sun IL; Crane FL; Chou JY; Löw H; Grebing C Biochem Biophys Res Commun; 1983 Oct; 116(1):210-6. PubMed ID: 6639658 [TBL] [Abstract][Full Text] [Related]
52. Quantitative cytochemical investigations on Ehrlich ascites tumour cells treated with Vincristine. II. Fast green cytophotometric investigations. Gyeskó A; Szentirmay Z; Sugár J Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 78(1):90-8. PubMed ID: 4263846 [No Abstract] [Full Text] [Related]
53. Rhein inhibits glucose uptake in Ehrlich ascites tumor cells by alteration of membrane-associated functions. Castiglione S; Fanciulli M; Bruno T; Evangelista M; Del Carlo C; Paggi MG; Chersi A; Floridi A Anticancer Drugs; 1993 Jun; 4(3):407-14. PubMed ID: 8358069 [TBL] [Abstract][Full Text] [Related]
54. Functional reconstitution of Ehrlich cell plasma membrane ferricyanide reductase. Medina MA; Núñez de Castro I Biochem Biophys Res Commun; 1994 Dec; 205(2):1109-13. PubMed ID: 7802639 [TBL] [Abstract][Full Text] [Related]
55. Stimulatory effect of acid glycopeptide of Ehrlich ascites tumour on cell multiplication. Jodezyk KJ; Farbiszewski R; Bańkowski E; Gabryel H Zentralbl Allg Pathol; 1983; 127(1-2):19-23. PubMed ID: 6858422 [No Abstract] [Full Text] [Related]
56. Identification of a Zn(2+)-sensitive component of Ehrlich cell plasma membrane redox system by CHAPS-agarose-polyacrylamide electrophoresis and in situ staining of activity. Rodríguez-Caso L; Rodríguez-Agudo D; del Castillo-Olivares A; Márquez J; Núñez de Castro I; Medina MA Biochem Mol Biol Int; 1997 Jan; 41(1):75-81. PubMed ID: 9043637 [TBL] [Abstract][Full Text] [Related]
57. Demonstration of repair of potentially lethal damage in plateau phase cells of Ehrlich ascites tumor after exposure to bleomycin. Takabe Y; Miyamoto T; Terashima T Gan; 1974 Dec; 65(6):559-60. PubMed ID: 4142871 [No Abstract] [Full Text] [Related]
58. Growth acceleration of Ehrlich ascites tumor cells treated by proteinase in vitro. Adamietz IA; Kurfürst F; Müller U; Renner K; Rimpler M Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1837-41. PubMed ID: 2632265 [TBL] [Abstract][Full Text] [Related]
59. The topography of some anionic sites at the surfaces of fixed Ehrlich ascites tumour cells. Weiss L; Jung OS; Zeigel R Int J Cancer; 1972 Jan; 9(1):48-56. PubMed ID: 5062746 [No Abstract] [Full Text] [Related]
60. Activity of bleomycin in iron- and copper-deficient cells. Lyman S; Taylor P; Lornitzo F; Wier A; Stone D; Antholine WE; Petering DH Biochem Pharmacol; 1989 Dec; 38(23):4273-82. PubMed ID: 2480795 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]